CEO, Arrowhead Pharmaceuticals
Chris Anzalone is an entrepreneur and biotech executive, serving as CEO, president, and director of Arrowhead Pharmaceuticals, where he has been since 2007. Arrowhead Pharmaceuticals develops drug treatments for genetically based diseases where proteins are overproduced, including those that affect the liver, lungs, and cardiovascular system. He is based out of Pasadena, California.
In addition to serving on the Health Advisory Board, Anzalone is a trustee at his alma mater, Lawrence University in Wisconsin.